...
首页> 外文期刊>International Journal of Clinical and Experimental Pathology >Primary hepatosplenic CD5-positive diffuse large B-cell lymphoma: a case report with literature review
【24h】

Primary hepatosplenic CD5-positive diffuse large B-cell lymphoma: a case report with literature review

机译:原发性肝脾CD5阳性弥漫性大B细胞淋巴瘤:病例报告并文献复习

获取原文
           

摘要

emDe novo/em CD5-positive diffuse large B-cell lymphoma (CD5sup+/sup DLBCL) accounts for approximately 10% of DLBCL, and is usually associated with aggressive clinical course. We report a case of CD5sup+/sup DLBCL with primary involvement of the spleen and liver, and no distinct mass lesions or lymphadenopathy. The patient had stage IV disease with bone marrow involvement by lymphoma. The lymphoma cells showed characteristic portal and intrasinusoidal pattern of infiltrate in the liver. The literature was reviewed and the clinicopathologic features of 7 similar reported cases were summarized. All cases share the common features of hepatosplenomegaly without mass lesions, exclusive red pulp infiltrate with a diffuse and cordal pattern in the spleen, portal and intrasinusoidal pattern of infiltrate in the liver, and stage IV disease with poor response to conventional chemotherapy. This may represent a distinct subgroup of CD5sup+/sup DLBCL and the diagnosis is important for prompt clinical treatment
机译:从头 CD5阳性的弥漫性大B细胞淋巴瘤(CD5 + DLBCL)约占DLBCL的10%,通常与侵袭性临床病程有关。我们报道一例CD5 + DLBCL,主要累及脾脏和肝脏,无明显肿块或淋巴结肿大。患者患有IV期疾病,淋巴瘤累及骨髓。淋巴瘤细胞表现出肝内浸润的特征性门静脉和窦内模式。本文回顾了文献,总结了7例类似病例的临床病理特征。所有病例均具有肝脾肿大的共同特征,无肿块病灶,仅红髓浸润,脾脏呈弥漫性和脐带状,肝浸润为门静脉和窦内形态,IV期疾病对常规化疗反应较差。这可能代表了CD5 + DLBCL的不同亚组,并且诊断对于及时临床治疗很重要

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号